Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration

SUMMARY STATEMENT: Intravitreal high dose (2 mg) ranibizumab may lead to quicker resolution of choroidal neovascularization (CNV) and associated retinal pigment epithelial detachment in eyes with exudative age-related macular degeneration, although it may possibly correlate with RPE tears in certain...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eye (Lond)
Main Authors: Chan, C K, Abraham, P, Sarraf, D, Nuthi, A S D, Lin, S G, McCannel, C A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289828/
https://ncbi.nlm.nih.gov/pubmed/25277305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.233
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados